Chill folks
we still have the RESULTS of the OLE onboarding and who knows what that brings. Given we have no patient that is on trial that has passed away, it isn’t going to be bad news.
There will be a number of things happen prior to any CR and I am certain a LOAD of brain power is going in to ensuring best value for shareholders. With the new chair on, I am sure he will be adding his thoughts to the mix.
PAA, A New Dawn , FDA ODD Approval and Entering Phase II MND Trial, page-128
-
- There are more pages in this discussion • 851 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
20.5¢ |
Change
0.005(2.50%) |
Mkt cap ! $99.71M | |||
| Open | High | Low | Value | Volume |
| 20.5¢ | 20.5¢ | 20.0¢ | $66.86K | 327.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 27750 | 20.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 20.5¢ | 84999 | 3 |
View Market Depth
| Last trade - 14.42pm 27/09/2024 (20 minute delay) ? |
| PAA (ASX) Chart |